puromycin aminonucleoside and endothelin-1

puromycin aminonucleoside has been researched along with endothelin-1 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebihara, I; Koide, H; Nakamura, T; Tomino, Y1
Chang, JM; Chen, HC; Guh, JY; Hwang, SJ; Lai, YH; Tsai, JC1
Ikebe, M; Nakayama, Y; Nonoguchi, H; Shimada, K; Tanzawa, K; Tashima, Y; Tomita, K1
Akagawa, Y; Kaneko, K; Kimata, T; Kino, J; Kitao, T; Tsuji, S; Yamanouchi, S1

Other Studies

4 other study(ies) available for puromycin aminonucleoside and endothelin-1

ArticleYear
Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Enalapril; Endothelin Receptor Antagonists; Endothelin-1; Extracellular Matrix; Gelatinases; Glycoproteins; Indoles; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Nephrosis; Protease Inhibitors; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger; Tissue Inhibitor of Metalloproteinases

1997
Plasma and urinary endothelin-1 in focal segmental glomerulosclerosis.
    Journal of clinical laboratory analysis, 2001, Volume: 15, Issue:2

    Topics: Adult; Animals; Disease Models, Animal; Endothelin-1; Female; Glomerulosclerosis, Focal Segmental; Humans; Injections, Subcutaneous; Male; Puromycin Aminonucleoside; Rats; Rats, Wistar

2001
Regulation of endothelin-converting enzyme 1 in nephrotic syndrome in rats.
    Nephron. Experimental nephrology, 2003, Volume: 94, Issue:4

    Topics: Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Bosentan; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelin-Converting Enzymes; Enzyme Induction; Gene Expression Regulation, Enzymologic; Kidney Glomerulus; Male; Metalloendopeptidases; Nephrons; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Time Factors

2003
Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
    Pediatric research, 2018, Volume: 83, Issue:5

    Topics: Animals; B7-1 Antigen; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Female; Kidney; Kidney Diseases; Kidney Glomerulus; Nephrosis; Nephrotic Syndrome; NF-kappa B; Phenylpropionates; Podocytes; Proteinuria; Puromycin Aminonucleoside; Pyridazines; Rats; Rats, Wistar; Receptor, Endothelin A; Toll-Like Receptor 3

2018